Considering distinct positive emotions in psychedelic science.
Sean P. Goldy, Peter S. Hendricks, Dacher Keltner, David B. Yaden
International Review of Psychiatry December 1, 2024 DOI: 10.1080/09540261.2024.2394221 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Psychedelics Affect Emotions |
| Citations | 8 |
| Key findings | Considering distinct positive emotions in psychedelic science could yield more precise statements about psychedelic-related subjective processes and outcomes. |
Abstract
In this review, we discuss psychedelics' acute subjective and persisting therapeutic effects, outline the science of positive emotions, and highlight the value in considering distinct positive emotions in psychedelic science. Psychedelics produce a wide variety of acute subjective effects (i.e. the 'trip'), including positive emotions and affective states such as awe and joy. However, despite a rich literature on distinct emotions and their different correlates and sequelae, distinct emotions in psychedelic science remain understudied. Insofar as psychedelics' acute subjective effects may play a role in their downstream therapeutic effects (e.g. decreased depression, anxiety, and substance misuse), considering the role of distinct positive emotions in psychedelic experiences has the potential to yield more precise statements about psychedelic-related subjective processes and outcomes. We propose here that understanding the role of positive emotions within the context of psychedelic experiences could help elucidate the connection between psychedelics' acute subjective effects and therapeutic outcomes.
Citations in the library
Cited by 6
- Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: a qualitative-quantitative approach. Consciousness and Cognition July 7, 2025
- Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy. Healthcare June 5, 2026
- DMT, Madness, and Healing: Psychosis Model, Therapy Model, and Their Relations to Mystical Experiences and Positive Emotionality Research Square May 20, 2026
- These aren’t the beliefs you’re looking for: on the limits of affect-neutral accounts of psychedelic therapy Synthese January 26, 2026
- From Science to Pleasure: Justifications of the Use of Classic Psychedelics in Finland. Nordisk Alkohol Nark December 30, 2025
and 1 more in the library
Cites 43
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
and 38 more in the library